Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Care | Research article

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey

Authors: Zsofia Rozsnyai, Katharina Tabea Jungo, Emily Reeve, Rosalinde K. E. Poortvliet, Nicolas Rodondi, Jacobijn Gussekloo, Sven Streit

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally, general practitioners (GPs), should regularly review medication lists to identify inappropriate medication(s) and, where appropriate, deprescribe. However, it remains challenging to deprescribe given time constraints and few recommendations from guidelines. Further, patient related barriers and enablers to deprescribing have to be accounted for. The aim of this study was to identify barriers and enablers to deprescribing as reported by older adults with polypharmacy and multimorbidity.

Methods

We conducted a survey among participants aged ≥70 years, with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 chronic medications). We invited Swiss GPs, to recruit eligible patients who then completed a paper-based survey on demographics, medications and chronic conditions. We used the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire and added twelve additional Likert scale questions and two open-ended questions to assess barriers and enablers towards deprescribing, which we coded and categorized into meaningful themes.

Result

Sixty four Swiss GPs consented to recruit 5–6 patients each and returned 300 participant responses. Participants were 79.1 years (SD 5.7), 47% female, 34% lived alone, and 86% managed their medications themselves. Sixty-seven percent of participants took 5–9 regular medicines and 24% took ≥10 medicines. The majority of participants (77%) were willing to deprescribe one or more of their medicines if their doctor said it was possible. There was no association with sex, age or the number of medicines and willingness to deprescribe. After adjustment for baseline characteristics, there was a strong positive association between willingness to deprescribe and saying that because they have a good relationship with their GP, they would feel that deprescribing was safe OR 11.3 (95% CI: 4.64–27.3) and agreeing that they would be willing to deprescribe if new studies showed an avoidable risk OR 8.0 (95% CI 3.79–16.9). From the open questions, the most mentioned barriers towards deprescribing were patients feeling well on their current medicines and being convinced that they need all their medicines.

Conclusions

Most older adults with polypharmacy are willing to deprescribe. GPs may be able to increase deprescribing by building trust with their patients and communicating evidence about the risks of medication use.
Appendix
Available only for authorised users
Literature
1.
go back to reference Salisbury C, et al. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.CrossRefPubMed Salisbury C, et al. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.CrossRefPubMed
2.
go back to reference Gnjidic D, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–95.CrossRefPubMed Gnjidic D, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–95.CrossRefPubMed
3.
go back to reference Van Spall HGC, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical JournalsA systematic sampling review. JAMA. 2007;297(11):1233–40.CrossRefPubMed Van Spall HGC, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical JournalsA systematic sampling review. JAMA. 2007;297(11):1233–40.CrossRefPubMed
4.
go back to reference Hughes LD, McMurdo MET, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2012;42(1):62–9.CrossRefPubMed Hughes LD, McMurdo MET, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2012;42(1):62–9.CrossRefPubMed
5.
go back to reference Guthrie B, et al. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342:d3514.CrossRefPubMed Guthrie B, et al. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342:d3514.CrossRefPubMed
6.
go back to reference Avery AJ, et al. The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Br J Gen Pract. 2013;63(613):e543–53.CrossRefPubMedPubMedCentral Avery AJ, et al. The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Br J Gen Pract. 2013;63(613):e543–53.CrossRefPubMedPubMedCentral
7.
go back to reference Dequito AB, et al. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands. Drug Saf. 2011;34(11):1089–100.CrossRefPubMed Dequito AB, et al. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands. Drug Saf. 2011;34(11):1089–100.CrossRefPubMed
8.
go back to reference Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303–12.CrossRefPubMed Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303–12.CrossRefPubMed
9.
go back to reference Fincke BG, Miller DR, Spiro A 3rd. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med. 1998;13(3):182–5.CrossRefPubMedPubMedCentral Fincke BG, Miller DR, Spiro A 3rd. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med. 1998;13(3):182–5.CrossRefPubMedPubMedCentral
10.
go back to reference Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRefPubMedPubMedCentral Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRefPubMedPubMedCentral
11.
go back to reference Reeve E, et al. A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.CrossRefPubMedPubMedCentral Reeve E, et al. A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.CrossRefPubMedPubMedCentral
12.
go back to reference Moriarty F, et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5(9):e008656.CrossRefPubMedPubMedCentral Moriarty F, et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5(9):e008656.CrossRefPubMedPubMedCentral
14.
go back to reference Lindsay J, et al. Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Support Care Cancer. 2014;22(4):1113–9.CrossRefPubMed Lindsay J, et al. Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Support Care Cancer. 2014;22(4):1113–9.CrossRefPubMed
15.
go back to reference Burge F, Lawson B, Mitchell G. How to move to a palliative approach to care for people with multimorbidity. BMJ. 2012;345:e6324.CrossRefPubMed Burge F, Lawson B, Mitchell G. How to move to a palliative approach to care for people with multimorbidity. BMJ. 2012;345:e6324.CrossRefPubMed
16.
go back to reference Barnett N, Jubraj B. A themed journal issue on deprescribing. Eur J Hosp Pharm Sci Pract. 2017;24(1):1–2.CrossRef Barnett N, Jubraj B. A themed journal issue on deprescribing. Eur J Hosp Pharm Sci Pract. 2017;24(1):1–2.CrossRef
17.
go back to reference Anderson K, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4. Anderson K, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4.
18.
go back to reference Reeve E, et al. Patient barriers to and enablers of Deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.CrossRefPubMed Reeve E, et al. Patient barriers to and enablers of Deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.CrossRefPubMed
19.
go back to reference Reeve E, et al. People's attitudes, beliefs, and experiences regarding Polypharmacy and willingness to Deprescribe. J Am Geriatr Soc. 2013;61(9):1508–14.CrossRefPubMed Reeve E, et al. People's attitudes, beliefs, and experiences regarding Polypharmacy and willingness to Deprescribe. J Am Geriatr Soc. 2013;61(9):1508–14.CrossRefPubMed
20.
go back to reference Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. Int J Clin Pharm. 2019;41(3):793–803.CrossRefPubMed Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. Int J Clin Pharm. 2019;41(3):793–803.CrossRefPubMed
21.
go back to reference Reeve E, et al. Assessment of attitudes toward Deprescribing in older Medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673–80.CrossRefPubMedPubMedCentral Reeve E, et al. Assessment of attitudes toward Deprescribing in older Medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673–80.CrossRefPubMedPubMedCentral
22.
go back to reference Aoki T, et al. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531–7.CrossRefPubMed Aoki T, et al. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531–7.CrossRefPubMed
23.
go back to reference Mantelli S, et al. How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study. BMC Fam Pract. 2018;19(1):169.CrossRefPubMedPubMedCentral Mantelli S, et al. How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study. BMC Fam Pract. 2018;19(1):169.CrossRefPubMedPubMedCentral
24.
go back to reference Reeve E, et al. Development and validation of the revised patients’ attitudes towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913–28.CrossRefPubMed Reeve E, et al. Development and validation of the revised patients’ attitudes towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913–28.CrossRefPubMed
26.
go back to reference von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.CrossRef von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.CrossRef
27.
go back to reference Research on multimorbidity in primary care. Selected abstracts from the EGPRN meeting in Tampere, Finland, 9–12 May 2019. Eur J Gen Pract. 2019;25(3):164–75.CrossRef Research on multimorbidity in primary care. Selected abstracts from the EGPRN meeting in Tampere, Finland, 9–12 May 2019. Eur J Gen Pract. 2019;25(3):164–75.CrossRef
29.
go back to reference Schiøtz ML, et al. Polypharmacy and medication deprescribing: a survey among multimorbid older adults in Denmark. Pharmacol Res Perspect. 2018;6(6):–e00431. Schiøtz ML, et al. Polypharmacy and medication deprescribing: a survey among multimorbid older adults in Denmark. Pharmacol Res Perspect. 2018;6(6):–e00431.
30.
go back to reference Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward Deprescribing. J Am Geriatr Soc. 2019;67(6):1204–10.CrossRefPubMed Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward Deprescribing. J Am Geriatr Soc. 2019;67(6):1204–10.CrossRefPubMed
31.
go back to reference Herzig L, et al. Factors associated with patients' and GPs' assessment of the burden of treatment in multimorbid patients: a cross-sectional study in primary care. BMC Fam Pract. 2019;20(1):88.CrossRefPubMedPubMedCentral Herzig L, et al. Factors associated with patients' and GPs' assessment of the burden of treatment in multimorbid patients: a cross-sectional study in primary care. BMC Fam Pract. 2019;20(1):88.CrossRefPubMedPubMedCentral
32.
go back to reference Komagamine J, Sugawara K, Hagane K. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study. BMC Geriatr. 2018;18(1):96.CrossRefPubMedPubMedCentral Komagamine J, Sugawara K, Hagane K. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study. BMC Geriatr. 2018;18(1):96.CrossRefPubMedPubMedCentral
33.
go back to reference Zechmann S, et al. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland. BMC Fam Pract. 2019;20(1):64.CrossRefPubMedPubMedCentral Zechmann S, et al. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland. BMC Fam Pract. 2019;20(1):64.CrossRefPubMedPubMedCentral
34.
go back to reference Blozik E, et al. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30(7):561–8.CrossRefPubMed Blozik E, et al. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30(7):561–8.CrossRefPubMed
35.
go back to reference Statistik, B.F., Altersaufbau der ständigen Wohnbevölkerung ab 15 Jahren, nach Migrationsstatus und Geschlecht, 2012–2018. 2019. Statistik, B.F., Altersaufbau der ständigen Wohnbevölkerung ab 15 Jahren, nach Migrationsstatus und Geschlecht, 2012–2018. 2019.
Metadata
Title
What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey
Authors
Zsofia Rozsnyai
Katharina Tabea Jungo
Emily Reeve
Rosalinde K. E. Poortvliet
Nicolas Rodondi
Jacobijn Gussekloo
Sven Streit
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Care
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01843-x

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.